Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. [electronic resource]
- Antimicrobial agents and chemotherapy Feb 2013
- 689-96 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1098-6596
10.1128/AAC.00877-12 doi
Aminoglycosides--therapeutic use Animals Anti-Bacterial Agents--therapeutic use Bacteroides--genetics Cecum--microbiology Clostridioides difficile--drug effects Clostridium Infections--drug therapy DNA, Bacterial--isolation & purification Enterocolitis, Pseudomembranous--drug therapy Feces--microbiology Fidaxomicin Intestines--drug effects Male Metronidazole--therapeutic use Mice Mice, Inbred C57BL Nitro Compounds Recurrence Thiazoles--therapeutic use Treatment Outcome Vancomycin--therapeutic use